1. Home
  2. OCS vs UTL Comparison

OCS vs UTL Comparison

Compare OCS & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • UTL
  • Stock Information
  • Founded
  • OCS 2003
  • UTL 1984
  • Country
  • OCS Switzerland
  • UTL United States
  • Employees
  • OCS N/A
  • UTL N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • UTL Power Generation
  • Sector
  • OCS Health Care
  • UTL Utilities
  • Exchange
  • OCS Nasdaq
  • UTL Nasdaq
  • Market Cap
  • OCS 956.4M
  • UTL 842.0M
  • IPO Year
  • OCS N/A
  • UTL N/A
  • Fundamental
  • Price
  • OCS $17.85
  • UTL $47.85
  • Analyst Decision
  • OCS Strong Buy
  • UTL Hold
  • Analyst Count
  • OCS 3
  • UTL 1
  • Target Price
  • OCS $35.67
  • UTL $55.00
  • AVG Volume (30 Days)
  • OCS 11.4K
  • UTL 114.2K
  • Earning Date
  • OCS 08-21-2025
  • UTL 08-04-2025
  • Dividend Yield
  • OCS N/A
  • UTL 3.76%
  • EPS Growth
  • OCS N/A
  • UTL N/A
  • EPS
  • OCS N/A
  • UTL 2.91
  • Revenue
  • OCS $960,668.00
  • UTL $493,800,000.00
  • Revenue This Year
  • OCS $11.49
  • UTL $13.90
  • Revenue Next Year
  • OCS $1,784.02
  • UTL $7.89
  • P/E Ratio
  • OCS N/A
  • UTL $16.46
  • Revenue Growth
  • OCS N/A
  • UTL N/A
  • 52 Week Low
  • OCS $10.79
  • UTL $46.65
  • 52 Week High
  • OCS $23.08
  • UTL $63.52
  • Technical
  • Relative Strength Index (RSI)
  • OCS 46.62
  • UTL 40.42
  • Support Level
  • OCS $17.51
  • UTL $46.65
  • Resistance Level
  • OCS $18.16
  • UTL $47.98
  • Average True Range (ATR)
  • OCS 0.36
  • UTL 1.29
  • MACD
  • OCS 0.01
  • UTL -0.22
  • Stochastic Oscillator
  • OCS 40.48
  • UTL 20.94

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About UTL UNITIL Corporation

Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.

Share on Social Networks: